Antifibrotic and Antioxidant Effects of a Tetrahedral Framework Nucleic Acid-Based Chlorogenic Acid Delivery System DOI
Lan Yao, Jiajie Li, Xin Qin

et al.

ACS Materials Letters, Journal Year: 2023, Volume and Issue: 5(4), P. 1153 - 1163

Published: March 13, 2023

Liver fibrosis, an early stage of cirrhosis, with large number patients and seriously endangering health, has no viable treatment available currently. In this study, we choose tetrahedral framework nucleic acid nanoparticles as carriers to deliver the polyphenolic monomer chlorogenic injured liver for first time. This delivery system enhanced bioavailability stability acid, laying foundation its antifibrotic antioxidant effects. Our findings show that approach can reduce fibrosis by down-regulating Smad2/3 phosphorylation, limiting extracellular matrix synthesis, substantially improving performance mouse livers restoring normal function; besides, promote reactive oxygen species consumption upregulating Nrf2, regulating oxidative stress alleviating multiorgan damage in mice. general, created a nanodelivery associated providing more possibilities clinical application small molecule drugs.

Language: Английский

Beta-elemene: A phytochemical with promise as a drug candidate for tumor therapy and adjuvant tumor therapy DOI Open Access

Yewen Feng,

Qingwen An,

Zhengqi Zhao

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 172, P. 116266 - 116266

Published: Feb. 13, 2024

β-Elemene (IUPAC name: (1 S,2 S,4 R)-1-ethenyl-1-methyl-2,4-bis(prop-1-en-2-yl) cyclohexane), is a natural compound found in turmeric root. Studies have demonstrated its diverse biological functions, including anti-tumor properties, which been extensively investigated. However, these not yet reviewed. The aim of this review was to provide comprehensive summary β-elemene research, with respect disease treatment.

Language: Английский

Citations

14

TGF-β signaling regulates differentiation of MSCs in bone metabolism: disputes among viewpoints DOI Creative Commons

Erfan Wei,

Menglong Hu,

Likun Wu

et al.

Stem Cell Research & Therapy, Journal Year: 2024, Volume and Issue: 15(1)

Published: May 31, 2024

Abstract Mesenchymal stem cells (MSCs) are multipotent that can differentiate into of different lineages to form mesenchymal tissues, which promising in regard treatment for bone diseases. Their osteogenic differentiation is under the tight regulation intrinsic and extrinsic factors. Transforming growth factor β (TGF-β) an essential metabolism, regulates MSCs. However, published studies differ their views on whether TGF-β signaling MSCs positively or negatively. The controversial results have not been summarized systematically related explanations required. Therefore, we reviewed basics how each three isoforms differentiation. Three (TGF-β1/β2/β3) play distinct roles regulating Additionally, other possible sources conflicts here. Further understanding may lead new applications promote regeneration improve therapies

Language: Английский

Citations

10

A dihydromyricetin-loaded phellinus igniarius polysaccharide/l-arginine modified chitosan-based hydrogel for promoting wound recovery in diabetic mice via JNK and TGF-β/Smad signaling pathway DOI
Jiali Yang, Lifeng Zhang, Shuwen Sun

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 259, P. 129124 - 129124

Published: Jan. 3, 2024

Language: Английский

Citations

9

Total Sanghuangporus vaninii extract inhibits hepatocyte ferroptosis and intestinal microbiota disturbance to attenuate liver fibrosis in mice DOI
Siqi Gao,

Xingxing Wang,

Qiuying Xu

et al.

Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 119571 - 119571

Published: Feb. 1, 2025

Language: Английский

Citations

1

Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions DOI Creative Commons
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy

et al.

Journal of Hepatology, Journal Year: 2022, Volume and Issue: 77(1), P. 219 - 236

Published: Feb. 12, 2022

HCV hijacks many host metabolic processes in an effort to aid viral replication. The resulting hepatic dysfunction underpins of the and extrahepatic manifestations chronic hepatitis C (CHC). However, natural history CHC is also substantially influenced by status: obesity, insulin resistance steatosis are major determinants progression toward hepatocellular carcinoma (HCC). Direct-acting antivirals (DAAs) have transformed treatment CHC. While DAA therapy effectively eradicates virus, long-lasting overlapping disease can persist, especially presence increasing risk liver progression. This review covers mechanisms which tunes systemic metabolism, highlighting how disturbance, lipotoxicity inflammation favour a precancerous niche. We highlight therapeutic implications sustained following virologic response as well considerations for patients who develop HCC on background dysfunction.

Language: Английский

Citations

38

Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer DOI Open Access

Sonia Ben Hamouda,

Khadija Essafi‐Benkhadir

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(6), P. 5600 - 5600

Published: March 15, 2023

The study of the tumor microenvironment (TME) has become an important part colorectal cancer (CRC) research. Indeed, it is now accepted that invasive character a primary CRC determined not only by genotype cells, but also their interactions with extracellular environment, which thereby orchestrates development tumor. In fact, TME cells are double-edged sword as they play both pro- and anti-tumor roles. interaction tumor-infiltrating (TIC) induces polarization TIC, exhibiting antagonist phenotype. This controlled plethora interconnected anti-oncogenic signaling pathways. complexity this dual function these different actors contribute to failure control. Thus, better understanding such mechanisms great interest provides new opportunities for personalized efficient therapies CRC. review, we summarize pathways linked implication in or inhibition initiation progression. second part, enlist major components discuss functions.

Language: Английский

Citations

22

CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens DOI Open Access
Jerin Thomas,

Addison Klebanov,

Sahara John

et al.

Genes & Cancer, Journal Year: 2023, Volume and Issue: 14, P. 12 - 29

Published: Feb. 1, 2023

The CEA family comprises 18 genes and 11 pseudogenes located at chromosome 19q13.2and is divided into two main groups: cell surface anchored CEA-related adhesion molecules (CEACAMs) the secreted pregnancy-specific glycoproteins (PSGs).CEACAMs are highly glycosylated anchored, intracellular, intercellular signaling with diverse functions, from differentiation transformation to modulating immune responses associated infection, inflammation, cancer.In this review, we explore current knowledge surrounding CEACAM1, CEACAM5, CEACAM6, highlight their pathological significance in areas of cancer biology, immunology, inflammatory disease, describe utility murine models exploring questions related these proteins.

Language: Английский

Citations

18

Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis DOI Creative Commons
Zhi Xiong Chong, Chean Yeah Yong, Han Kiat Ong

et al.

Toxicology, Journal Year: 2023, Volume and Issue: 495, P. 153596 - 153596

Published: July 20, 2023

Aryl hydrocarbon receptor (AHR) is a ligand-dependent that belongs to the superfamily of basic helix-loop-helix (bHLH) transcription factors. The activation canonical AHR signaling pathway known induce expression cytochrome P450 enzymes, facilitating detoxification metabolism in human body. Additionally, could interact with various pathways such as epidermal growth factor (EGFR), signal transducer and activator 3 (STAT3), hypoxia-inducible factor-1α (HIF-1α), nuclear kappa B (NF-κβ), estrogen (ER), androgen (AR) pathways. Over past 30 years, several studies have reported chemical, physical, or biological agents, tobacco, compounds, industrial agricultural chemical wastes, drugs, UV, viruses, other toxins, affect activity, promoting cancer development. Thus, it valuable overview how these factors regulate AHR-mediated carcinogenesis. Current findings many compounds act ligands drive expressions AHR-target genes, CYP1A1, CYP1B1, MMPs, AXL, targets exert pro-proliferation anti-apoptotic effect, like XIAP. Furthermore, some physical UV 3-methylcholanthrene, promote activities, increasing activities few oncogenic pathways, phosphatidylinositol 3-kinase/protein kinase (PI3K/AKT) mitogen-activated protein kinase/extracellular signal-regulated (MAPK/ERK) Understanding carcinogenesis processes helps clinicians scientists plan personalized therapeutic strategies improve anti-cancer treatment efficacy. As roles regulating are preclinical observational clinical did not explore detailed mechanisms different agents processes, future should focus on conducting large-scale functional unravel underlying mechanism interacts processes.

Language: Английский

Citations

18

TGFβ and the Tumor Microenvironment in Colorectal Cancer DOI Creative Commons

Maximilian J. Waldner,

Markus F. Neurath

Cells, Journal Year: 2023, Volume and Issue: 12(8), P. 1139 - 1139

Published: April 12, 2023

Growing evidence supports an important role of the tumor microenvironment (TME) in pathogenesis colorectal cancer (CRC). Resident cells such as fibroblasts or immune infiltrating into TME maintain continuous crosstalk with and thereby regulate CRC progression. One most molecules involved is immunoregulatory cytokine transforming growth factor-β (TGFβ). TGFβ released by various TME, including macrophages fibroblasts, it modulates cell growth, differentiation, death. Mutations components TGF pathway, receptor type 2 SMAD4, are among frequently detected mutations have been associated clinical course disease. Within this review, we will discuss our current understanding about CRC. This includes novel data on molecular mechanisms signaling well possible strategies for therapy targeting potential combinations checkpoint inhibitors.

Language: Английский

Citations

17

From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems DOI
Jiaojiao Yang,

Dingwei Li,

Mengjiao Zhang

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 361, P. 568 - 591

Published: Aug. 15, 2023

Language: Английский

Citations

17